Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Change in Cash (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Change in Cash for 2 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 18.67% to $3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19832.0 through Dec 2025, down 99.47% year-over-year, with the annual reading at $19832.0 for FY2025, 99.47% down from the prior year.
  • Change in Cash for Q4 2025 was $3.1 million at Jupiter Neurosciences, up from -$1.2 million in the prior quarter.
  • The five-year high for Change in Cash was $3.8 million in Q4 2024, with the low at -$1.2 million in Q3 2025.